Journal of Clinical Endocrinology & Metabolism, Vol 81, 1416-1419, Copyright © 1996 by Endocrine Society

ARTICLES

Calorigenic effects of growth hormone: the role of thyroid hormones

T Wolthers, T Groftne, N Moller, JS Christiansen, H Orskov, J Weeke and JO Jorgensen
Medical Department M, Aarhus University Hospital, Denmark.

GH administration increases energy expenditure, independent of changes in lean body mass, in healthy, obese, and GH-deficient subjects. This may be causally linked to the well known GH-induced increase in peripheral T4 to T3 generation, but experimental data are sparse. In this study we have addressed whether 1) the calorigenic effects of GH administration could be reproduced by oral supplementation of T3 in a dose selected to mimic the GH-induced increase in peripheral T3 levels; and 2) combined GH and T3 administration have a synergistic effect on resting energy expenditure (REE). Eight normal male subjects (aged 21- 27 yr; body mass index, 21.11-27.17 kg/m2) were randomly studied during four 10-day treatment periods with 1) daily sc placebo injections and placebo tablets, 2) daily sc GH injections (0.1 IU/kg x day) and placebo tablets, 3) daily T3 administration (40 microg on even dates, 20 microg on uneven dates) plus placebo injections, and 4) daily GH injections plus T3 administration. GH administration increased both free T3 (FT3) levels [mean +/- SE, 6.2 +/- 0.3 (control) vs. 7.3 +/- 0.5 (GH) pmol/L; P < 0.05] and REE [mean +/- SE, 1959 +/- 67 (control) vs. 2164 +/- 55 (GH) Cal/24 h; P < 0.01]. T3 administration yielded comparable levels of FT3 (7.7 +/- 0.5 pmol/L; T3 vs. GH, P = 0.37), but did not increase REE (2015 +/- 48 Cal/24 h; T3 vs. control, P = 0.23). Combined GH and T3 administration increased REE to a level higher than that seen with T3 alone (2279 +/- 68 Cal/24 h; T3 vs. GH plus T3, P < 0.01). Significant increments in serum levels of insulin-like growth factor I and insulin were recorded with GH administration, but not with T3 alone. Resting heart rate increased to a similar degree after GH administration and T3 supplementation, respectively. Tympanic temperature remained unaltered in all four studies. The results suggest that the calorigenic effect of GH is not mediated solely through increased conversion of T4 to T3.

This article has been cited by other articles:

				H. Liu, D. M. Bravata, I. Olkin, A. Friedlander, V. Liu, B. Roberts, E. Bendavid, O. Saynina, S. R. Salpeter, A. M. Garber, et al. Systematic Review: The Effects of Growth Hormone on Athletic Performance Ann Intern Med, May 20, 2008; 148(10): 747 - 758. [Abstract] [Full Text] [PDF]

				J. D. Veldhuis, J. N. Roemmich, E. J. Richmond, A. D. Rogol, J. C. Lovejoy, M. Sheffield-Moore, N. Mauras, and C. Y. Bowers Endocrine Control of Body Composition in Infancy, Childhood, and Puberty Endocr. Rev., February 1, 2005; 26(1): 114 - 146. [Abstract] [Full Text] [PDF]

				B. Olsson, M. Bohlooly-Y, S. M. Fitzgerald, F. Frick, A. Ljungberg, B. Ahren, J. Tornell, G. Bergstrom, and J. Oscarsson Bovine Growth Hormone Transgenic Mice Are Resistant to Diet-Induced Obesity but Develop Hyperphagia, Dyslipidemia, and Diabetes on a High-Fat Diet Endocrinology, February 1, 2005; 146(2): 920 - 930. [Abstract] [Full Text] [PDF]

				J. L. Spadano, L. G. Bandini, A. Must, G. E. Dallal, and W. H. Dietz Does menarche mark a period of elevated resting metabolic rate? Am J Physiol Endocrinol Metab, March 1, 2004; 286(3): E456 - E462. [Abstract] [Full Text]

				H. Mersebach, O. L. Svendsen, A. Astrup, and U. Feldt-Rasmussen Abnormal Sympathoadrenal Activity, but Normal Energy Expenditure in Hypopituitarism J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 5689 - 5695. [Abstract] [Full Text] [PDF]

				M. Bramnert, M. Segerlantz, E. Laurila, J. R. Daugaard, P. Manhem, and L. Groop Growth Hormone Replacement Therapy Induces Insulin Resistance by Activating the Glucose-Fatty Acid Cycle J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1455 - 1463. [Abstract] [Full Text] [PDF]

				K. H. W. Lange, B. Larsson, A. Flyvbjerg, R. Dall, M. Bennekou, M. H. Rasmussen, H. Orskov, and M. Kjaer Acute Growth Hormone Administration Causes Exaggerated Increases in Plasma Lactate and Glycerol during Moderate to High Intensity Bicycling in Trained Young Men J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 4966 - 4975. [Abstract] [Full Text] [PDF]

				S. B. Pedersen, K. Kristensen, S. Fisker, J. O. L. Jørgensen, J. S. Christiansen, and B. Richelsen Regulation of Uncoupling Protein-2 and -3 by Growth Hormone in Skeletal Muscle and Adipose Tissue in Growth Hormone-Deficient Adults J. Clin. Endocrinol. Metab., November 1, 1999; 84(11): 4073 - 4078. [Abstract] [Full Text]

				J. N. Roemmich, P. A. Clark, V. Mai, S. S. Berr, A. Weltman, J. D. Veldhuis, and A. D. Rogol Alterations in Growth and Body Composition During Puberty: III. Influence of Maturation, Gender, Body Composition, Fat Distribution, Aerobic Fitness, and Energy Expenditure on Nocturnal Growth Hormone Release J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1440 - 1447. [Abstract] [Full Text]

				K. Mulligan, V. W. Tai, and M. Schambelan Effects of Chronic Growth Hormone Treatment on Energy Intake and Resting Energy Metabolism in Patients with Human Immunodeficiency Virus-Associated Wasting--A Clinical Research Center Study J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1542 - 1547. [Abstract] [Full Text]

				K. Stenlof, J.-O. Johansson, L. Lonn, L. Sjostrom, and B.-A. Bengtsson Diurnal Variations in Twenty-Four-Hour Energy Expenditure During Growth Hormone Treatment of Adults with Pituitary Deficiency J. Clin. Endocrinol. Metab., April 1, 1997; 82(4): 1255 - 1260. [Abstract] [Full Text] [PDF]